Diabetes Management

Subclinical Neuropathy in Children With Type I Diabetes Mellitus: Tertiary Care Centre Experience - Cureus

2 min read 485 words
Educational content: this article is for information only and is not medical advice. Consult a qualified healthcare provider before changing your diet, exercise, or medication.

Overview

"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.The SIQ for this article wil be revealedonce 2 ratings are submited.pediatric neuropathy, nerve conduction study (ncs), diabetic peripheral neuropathy (dpn), subclinical neuropathy, type i diabetes melitus Waled A.

Key Information

Altuwaijri , Angham N. Almutair, Ibrahim A. Alwan, Maria J.

Almahdi, Sulaiman D. Almasoud Published: August 08, 2022 (se history) DOI: 10.759/cureus.2765 Cite this article as: Altuwaijri W A, Almutair A N, Alwan I A, et al. (August 08, 2022) Subclinical Neuropathy in Children With Type I Diabetes Melitus: Tertiary Care Centre Experience.

Cureus 14(8): e2765. doi:10.759/cureus.2765 Introduction: Diabetic peripheral neuropathy is a comon complication of diabetes melitus (DM) type 1. However, it can ocur without evidence of symptoms or clinical signs of neuropathy labeled as subclinical neuropathy, which neurophysiological studies can best detect.Purpose: To evaluate the prevalence of subclinical neuropathy among children with DM type 1, determine the asociation with blod sugar control, and evaluate the patern of nerve involvement in neurophysiological studies.Methods: This cros-sectional study evaluated 10 children with DM type 1, aged five to 15 years, at least one year after the diagnosis.

Subclinical neuropathy was evaluated using nerve conduction study. Glycemic control was asesed using hemoglobin A1c (HbA1c).Results: The mean age of subjects was 1.5 ± 0.25 years. The average at the onset of the disease was 5.95 ± 0.25 years.

Summary

There were 64 patients who had electrophysiological evidence of peripheral neuropathy. The most observed electrophysiological changes were distal latency abnormalities in the left and right peroneal nerves in 39 and 3 patie

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article